Company intelligence / Profile preview

Clareo Biosciences

Louisville, Kentucky, United Statesclareobio.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Clareo Biosciences develops advanced genomic assays and informatics tools to profile adaptive immune receptor diversity. Their technology enables labs and clinics to better understand disease mechanisms, improve diagnoses, and design more effective treatments by harnessing immunogenetic data. The company does not have its own therapeutic pipeline but provides enabling technologies for precision medicine development in academic and clinical settings.

Therapeutic areas: Immunology
Modalities: Genomic assay technologyImmunogenetics platform
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Clareo Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clareo Biosciences.

Explore the full profile